IL7R and neoplasm: IL-7Rα expression in OVA-CD8+ T cells was statistically higher in tumor-bearing mice by day 30 (Figure 4D), but may be a result of IL-7Rαlow CD8+ T cells trafficking to the tumor site to exert effector functions.